Bavachin, Bavachinin, Maesopsin, Garcinoic Acid, and Bilobol as Anaplastic Lymphoma Kinase Inhibitors: In Vitro and in Silico Studies

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 374

فایل این مقاله در 13 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJCCE-44-5_018

تاریخ نمایه سازی: 16 خرداد 1404

چکیده مقاله:

Several new natural compounds were investigated as ALK inhibitor compounds. Bavachin, bavachinin, maesopsin, garcinoic acid, and bilobol Compounds, which have active groups, and also can inhibit ALK enzymatic tests (IC۵۰: ۰.۰۱۸ ± ۰.۰۰۷, ۱.۸۳۰ ± ۰.۰۱۲, ۹.۱۴۱ ± ۰.۳۰۱, ۰.۰۴۸ ± ۰.۰۰۳, and ۰.۹۷۰ ± ۰.۰۳۰ μM, respectively). Bavachin, Garcinoic acid, and Bilobol were identified as the best inhibitors, and then the antiproliferative activity of these compounds was studied. Additionally, the studies continued with bilobol, Bilobol against various receptor tyrosine Kinases, various ALK Mutants, CYP۴۵۰ Enzymes, and hERG studies were performed, and comparisons were made with standards. The investigation of the biological activities of certain natural compounds against a variety of enzymes was conducted using molecular modeling and molecular simulation. Computational techniques were utilized to assess the effectiveness of the natural compounds in inhibiting ALK and specific mutations of this kinase. Additionally, the binding affinity of these compounds to various receptor tyrosine kinases, including EGFR, c-Met, VEGFR۲, c-Src, IGF۱R, and JAK۲, was analyzed. The results emphasized the interactions between atoms, demonstrating that the compounds formed strong connections with the proteins. These natural compounds exhibit the potential to suppress enzyme activity and hinder the proliferation of cancer cells. Natural products have long been the sole source of viable lead compounds for medicinal chemists. They have also given clinical practice access to a large number of potential medication candidates for the therapy of a variety of conditions.

نویسندگان

Ling Wang

Department of Hematology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, ۷۱۰۰۶۸, P.R. CHINA

Hong Zhang

Department of Hematology, Shaanxi Provincial People's Hospital, Xi'an, Shaanxi, ۷۱۰۰۶۸, P.R. CHINA

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Huang M., Lu J.J., Ding J., Natural Products in Cancer ...
  • Wang F., Xu G., Wu X., Cardiac Arrhythmias Associated with ...
  • Mihăşan M., What in Silico Molecular Docking Can Do for ...
  • Poustforoosh A., Hashemipour H., Pardakhty A., Pour M.K., Preparation of ...
  • Naghiyev F., Mamedov I., Askerov R., Taslimi P., Poustforoosh A., ...
  • Jahantigh H., Ahmadi N., Lovreglio P., Stufano A., Enayatkhani M., ...
  • Guan J., Chuang T.P., Vikström A., Palmer R.H., Hallberg B., ...
  • Luo R., Fu W., Shao J., Ma L., Shuai S., ...
  • Wang K.L., Yeh T.Y., Hsu P.C., Wong T.H., Liu J.R., ...
  • Gou W., Li Z., Xu X., Shen J., Guo M., ...
  • Recondo G., Mezquita L., Facchinetti F., Planchard D., Gazzah A., ...
  • Garić D., Dumut D.C., Centorame A., Radzioch D., Western Blotting ...
  • Guengerich F.P., Inhibition of Cytochrome P۴۵۰ Enzymes by Drugs—Molecular Basis ...
  • Mehrabani M., Raeiszadeh M., Najafipour H., Esmaeli Tarzi M., Amirkhosravi ...
  • Fazel R., Hassani B., Zare F., Jokar Darzi H., Khoshneviszadeh ...
  • Schrödinger Release ۲۰۲۱-۳. (۲۰۲۱a). Maestro, S., LLC, New York, NY ...
  • Schrödinger Release ۲۰۲۱-۳. (۲۰۲۱b). “Protein Preparation Wizard”; Epik, S., LLC, ...
  • Poustforoosh A., Hashemipour H., Tüzün B., Pardakhty A., Mehrabani M., ...
  • Schrödinger Release ۲۰۲۱-۳. LigPrep, S., LLC, New York, NY (۲۰۲۱c) ...
  • Poustforoosh A., Farmarz S., Nematollahi M.H., Hashemipour H., Pardakhty A., ...
  • Poustforoosh A., Faramarz S., Nematollahi M.H., Mahmoodi M., Azadpour M., ...
  • Türkan F., Taslimi P., Cabir B., Ağırtaş M.S., Erden Y., ...
  • Taysi M.R., Kirici M., Kirici M., Tuzun B., Poustforoosh A., ...
  • Schrödinger Release ۲۰۲۱-۳: Desmond Molecular Dynamics System, D.E.S.R., New York, ...
  • Poustforoosh A., Faramarz S., Nematollahi M.H., Hashemipour H., Negahdaripour M., ...
  • Poustforoosh A., The Impact of Cationic/Anionic Ratio on the Physicochemical ...
  • Rashedinia M., Rasti Arbabi Z., Sabet R., Emami L., Poustforoosh ...
  • Poustforoosh A., Investigation on the Structural and Dynamical Properties of ...
  • El Rhabori S., Alaqarbeh M., Allouche Y.E., Naanaai L., El ...
  • Brenner A.K., Gunnes M.W., Therapeutic Targeting of the Anaplastic Lymphoma ...
  • Stiefel J., Kushner B.H., Roberts S.S., Iglesias-Cardenas F., Kramer K., ...
  • Harrison P.T., Vyse S., Huang P.H., Rare Epidermal Growth Factor ...
  • Iannantuono G.M., Riondino S., Sganga S., Roselli M., Torino F., ...
  • Kırıcı M., Tüzün B., Kırıcı M., Atamanalp M., Poustforoosh A., ...
  • Kafa A.H.T., Tüzün G., Güney E., Aslan R., Sayın K., ...
  • Mermer A., Bulbul M.V., Kalender S.M., Keskin I., Tuzun B., ...
  • Poustforoosh A., Faramarz S., Negahdaripour M., Hashemipour H., Modeling and ...
  • Poustforoosh A., Faramarz S., Negahdaripour M., Tüzün B., Hashemipour H., ...
  • Poustforoosh A., Faramarz S., Negahdaripour M., Tüzün B., Hashemipour H., ...
  • Poustforoosh A., Nematollahi M.H., Hashemipour H., Pardakhty A., Recent Advances ...
  • Asadikaram G., Poustforoosh A., Pardakhty A., Torkzadeh-Mahani M., Nematollahi M.H., ...
  • Talat Mehrabad J., Arjomandi Rad F., Mastourian S., Molecular Simulation ...
  • Anti-Bladder Cancer and Anti-Alzheimer Properties of Bavachin and Bavachinin as Natural Compounds with Molecular Docking and Dynamic Studies: In Vitro and in Silico Studies [مقاله ژورنالی]
  • Maesopsin as MAO-A, MAO-B, and AChE Inhibitors and Investigation of Anti-Lung and Anti-Colon Cancer Effects with Molecular Docking, Binding Free Energy Calculation, and Dynamics Simulation Studies [مقاله ژورنالی]
  • Khandan A., Khosravi M., Roustazadeh D., Aghadavoudi F., Impact of ...
  • Hussien S.A.H., Electronic Structure, Biological Activity, Spectral Analysis, NBO, NLO, ...
  • Salehpour P., Yegani R., Hajmohammadi R., Determination of Optimal Operation ...
  • نمایش کامل مراجع